Task force recommends clinicians offer high-risk patients pill to prevent HIV

The U.S. Preventive Services Task Force yesterday issued a draft recommendation that clinicians offer pre-exposure prophylaxis (PrEP), a daily pill that helps prevent HIV, to people at high risk for HIV. The task force also continued to recommend that clinicians screen all Americans aged 15 to 65 and pregnant women for HIV, as well as younger adolescents and older adults at increased risk for the virus. The panel will accept comments on the draft recommendations through Dec. 26.